OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis

Diabetologia

Volumn 58, Issue 8, 2015, Pages 1787-1796

  Helminen, Olli ^a   Aspholm, Susanna ^b   Pokka, Tytti ^a   Ilonen, Jorma ^c,d   Simell, Olli ^c   Veijola, Riitta ^a   Knip, Mikael ^b,e,f,g  

^a OULU UNIVERSITY HOSPITAL   (Finland)

^b TAMPERE UNIVERSITY HOSPITAL   (Finland)

^c UNIVERSITY OF TURKU   (Finland)

^d UNIVERSITY OF EASTERN FINLAND   (Finland)

^e UNIVERSITY OF HELSINKI AND HELSINKI UNIVERSITY HOSPITAL   (Finland)

^f UNIVERSITY OF HELSINKI   (Finland)

^g FOLKHÄLSAN RESEARCH CENTER   (Finland)

Author keywords

Children; Dysglycaemia; Islet autoimmunity; OGTT; Plasma glucose; Type 1 diabetes

Indexed keywords

AUTOANTIBODY; GLUCOSE; HLA ANTIGEN; BIOLOGICAL MARKER; GLUCOSE BLOOD LEVEL;

ADOLESCENT; ARTICLE; BLOOD GLUCOSE MONITORING; BLOOD SAMPLING; CHILD; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED STUDY; DIABETES MELLITUS; DIABETIC PATIENT; DIAGNOSTIC TEST ACCURACY STUDY; DIET RESTRICTION; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; GLUCOSE TOLERANCE; HAZARD RATIO; HLA TYPING; HUMAN; IMPAIRED FASTING GLUCOSE; IMPAIRED GLUCOSE TOLERANCE; INFANT; INSULIN DEPENDENT DIABETES MELLITUS; MAJOR CLINICAL STUDY; MALE; NEWBORN; ORAL GLUCOSE TOLERANCE TEST; PANCREAS ISLET; PREDICTIVE VALUE; PRIORITY JOURNAL; RANDOM PLASMA GLUCOSE; RECEIVER OPERATING CHARACTERISTIC; RISK FACTOR; SENSITIVITY AND SPECIFICITY; ANALYSIS; BLOOD; DIABETES MELLITUS, TYPE 1; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; PRESCHOOL CHILD; RETROSPECTIVE STUDY; TIME;

ADOLESCENT; AUTOANTIBODIES; BIOMARKERS; BLOOD GLUCOSE; CHILD; CHILD, PRESCHOOL; DIABETES MELLITUS, TYPE 1; FEMALE; GLUCOSE INTOLERANCE; GLUCOSE TOLERANCE TEST; HUMANS; INFANT; INFANT, NEWBORN; MALE; RETROSPECTIVE STUDIES; TIME FACTORS;

EID: 84937522573     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3621-9     Document Type: Article

References (30)

1. DIAMOND Project Group (2006) Incidence and trends of childhood type 1 diabetes worldwide 1990-1999. Diabet Med 23:857–866
2. Harjutsalo V, Sjoberg L, Tuomilehto J (2008) Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study. Lancet 371:1777–1782
3. Siljander HT, Simell S, Hekkala A et al (2009) Predictive characteristics of diabetes-associated autoantibodies among children with HLA-conferred disease susceptibility in the general population. Diabetes 58:2835–2842
4. Ziegler AG, Rewers M, Simell O et al (2013) Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children. JAMA 309:2473–2479
5. Siljander HT, Hermann R, Hekkala A et al (2013) Insulin secretion and sensitivity in the prediction of type 1 diabetes in children with advanced beta-cell autoimmunity. Eur J Endocrinol 169:479–485
6. Sosenko JM, Skyler JS, Herold KC, Palmer JP, Type 1 Diabetes TrialNet and Diabetes Prevention Trial–Type 1 Study Groups (2012) The metabolic progression to type 1 diabetes as indicated by serial oral glucose tolerance testing in the Diabetes Prevention Trial–Type 1. Diabetes 61:1331–1337
7. Sosenko JM, Skyler JS, Mahon J et al (2012) The application of the Diabetes Prevention Trial–Type 1 Risk Score for identifying a preclinical state of type 1 diabetes. Diabetes Care 35:1552–1555
8. Ferrannini E, Mari A, Nofrate V, Sosenko JM, Skyler JS, DPT-1 Study Group (2010) Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset. Diabetes 59:679–685
9. Sosenko JM, Palmer JP, Greenbaum CJ et al (2006) Patterns of metabolic progression to type 1 diabetes in the Diabetes Prevention Trial–Type 1. Diabetes Care 29:643–649
10. 1c predicts time to diagnosis of type 1 diabetes in children at risk. Diabetes 64:1719–1727
11. Elding Larsson H, Vehik K, Gesualdo P et al (2014) Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease. Pediatr Diabetes 15:118–126
12. 1c at diabetes onset. Diabetes Care 32:769–773
13. Barker JM, Goehrig SH, Barriga K et al (2004) Clinical characteristics of children diagnosed with type 1 diabetes through intensive screening and follow-up. Diabetes Care 27:1399–1404
14. Alberti KG, Zimmet PZ (1998) Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus. Provisional report of a WHO consultation. Diabet Med 15:539–553
15. Sosenko JM, Palmer JP, Rafkin-Mervis L et al (2009) Incident dysglycemia and progression to type 1 diabetes among participants in the Diabetes Prevention Trial–Type 1. Diabetes Care 32:1603–1607
16. Beer SF, Heaton DA, Alberti KG, Pyke DA, Leslie RD (1990) Impaired glucose tolerance precedes but does not predict insulin-dependent diabetes mellitus: a study of identical twins. Diabetologia 33:497–502
17. Hermann R, Knip M, Veijola R et al (2003) Temporal changes in the frequencies of HLA genotypes in patients with type 1 diabetes—indication of an increased environmental pressure? Diabetologia 46:420–425
18. Hekkala A, Ilonen J, Knip M, Veijola R, Finnish Paediatric Diabetes Register (2011) Family history of diabetes and distribution of class II HLA genotypes in children with newly diagnosed type 1 diabetes: effect on diabetic ketoacidosis. Eur J Endocrinol 165:813–817
19. Report WHO (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. WHO Document Production Services, Geneva
20. Siljander HT, Veijola R, Reunanen A, Virtanen SM, Akerblom HK, Knip M (2007) Prediction of type 1 diabetes among siblings of affected children and in the general population. Diabetologia 50:2272–2275
21. Aly TA, Ide A, Jahromi MM et al (2006) Extreme genetic risk for type 1A diabetes. Proc Natl Acad Sci U S A 103:14074–14079
22. Parikka V, Nanto-Salonen K, Saarinen M et al (2012) Early seroconversion and rapidly increasing autoantibody concentrations predict prepubertal manifestation of type 1 diabetes in children at genetic risk. Diabetologia 55:1926–1936
23. Nanto-Salonen K, Kupila A, Simell S et al (2008) Nasal insulin to prevent type 1 diabetes in children with HLA genotypes and autoantibodies conferring increased risk of disease: a double-blind, randomised controlled trial. Lancet 372:1746–1755
24. Greenbaum CJ, Cuthbertson D, Krischer JP, Disease Prevention Trial of Type I Diabetes Study Group (2001) Type I diabetes manifested solely by 2-h oral glucose tolerance test criteria. Diabetes 50:470–476
25. Bleich D, Jackson RA, Soeldner JS, Eisenbarth GS (1990) Analysis of metabolic progression to type I diabetes in ICA+ relatives of patients with type I diabetes. Diabetes Care 13:111–118
26. Tarn AC, Smith CP, Spencer KM, Bottazzo GF, Gale EA (1987) Type I (insulin dependent) diabetes: a disease of slow clinical onset? Br Med J (Clin Res Ed) 294:342–345
27. Sosenko JM, Mahon J, Rafkin L et al (2011) A comparison of the baseline metabolic profiles between Diabetes Prevention Trial–Type 1 and TrialNet Natural History Study participants. Pediatr Diabetes 12:85–90
28. Sosenko JM, Krischer JP, Palmer JP et al (2008) A risk score for type 1 diabetes derived from autoantibody-positive participants in the Diabetes Prevention Trial–Type 1. Diabetes Care 31:528–533
29. Sosenko JM, Skyler JS, Mahon J et al (2014) Use of the Diabetes Prevention Trial–Type 1 Risk Score (DPTRS) for improving the accuracy of the risk classification of type 1 diabetes. Diabetes Care 37:979–984
30. Ilonen J, Hammais A, Laine AP et al (2013) Patterns of beta-cell autoantibody appearance and genetic associations during the first years of life. Diabetes 62:3636–3640